Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

What does the future of clinical trials and evidence-based medicine look like?

In a recent perspective published in Nature Medicine, the researcher shared his vision and future perspectives for the domains of clinical research and evidence-based therapeutics.

18 Jan 2023

COVID-19 is changing behaviors related to how people are exposed to household chemicals

COVID-19 is changing household behaviors related to how we are exposed to various household chemicals linked to poor health outcomes.

18 Jan 2023

Threshold control method could aid in future non-pharmaceutical intervention relaxation policy making

Governments around the world used a variety of techniques known as nonpharmaceutical interventions, or NPIs, to control the spread of COVID-19.

18 Jan 2023

Exploring a novel amplicon-based mpox virus sequencing strategy

Researchers described the development of a sequencing strategy based on amplicons for mpox detection.

18 Jan 2023

What older Americans need to know about taking Paxlovid

A new coronavirus variant is circulating, the most transmissible one yet. Hospitalizations of infected patients are rising. And older adults represent nearly 90% of U.S. deaths from covid-19 in recent months, the largest portion since the start of the pandemic.

18 Jan 2023

After a brief pandemic reprieve, rural workers return to life without paid leave

When Ruby B. Sutton found out she was pregnant in late 2021, it was hard to envision how her full-time job would fit with having a newborn at home.

18 Jan 2023

Cancer mortality in the U.S. has declined 33% since the 90s

The American Cancer Society has recently published the statistics of cancer incidence and mortality for 2023 in CA: A Cancer Journal for Clinicians.

17 Jan 2023

Future COVID-19 control will require vaccines that induce better mucosal immunity

In a recent study posted to the medRxiv* preprint server, researchers in France explored the relationship between long-term immunoglobulin (Ig)-A response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and taste and smell disorders.

17 Jan 2023

Modification to Hospital Elder Life Program expands delirium prevention

A new study published in the Journal of American Geriatrics Society (JAGS) found that modifying a well-established and highly successful delirium prevention program for use when in-person or face-to-face interactions are limited or restricted is both feasible and acceptable to hospital staff and patients.

17 Jan 2023

Rural seniors benefit from pandemic-driven remote fitness boom

Eight women, all 73 or older, paced the fellowship hall at Malmo Evangelical Free Church to a rendition of Daniel O'Donnell's "Rivers of Babylon" as they warmed up for an hourlong fitness class.

17 Jan 2023

New community diagnostic center set to benefit thousands of patients in Stockton-on-Tees

Thousands of patients in Stockton-on-Tees are set to benefit from quicker access to tests, checks and scans - with a new community diagnostic center set to open later this year.

16 Jan 2023

New type of CT scan lights up the obvious cause of hypertension

Doctors at Queen Mary University of London and Barts Hospital, and Cambridge University Hospital, have led research using a new type of CT scan to light up tiny nodules in a hormone gland and cure high blood pressure by their removal. The nodules are discovered in one-in-twenty people with high blood pressure.

16 Jan 2023

Intranasal mRNA-lipid nanoparticle vaccines elicit significant protection against SARS-CoV-2 in hamsters

Researchers from the United States evaluated the efficacy and immunogenicity of an intranasal messenger ribonucleic acid (mRNA)-lipid nanoparticle (LNP) vaccine against SARS-CoV-2 using a hamster model.

16 Jan 2023

What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?

Researchers assessed the efficacy of the COVID-19 second booster vaccine compared to the first booster vaccine and the protection conferred by prior COVID-19 infection.

16 Jan 2023

Study investigates the spectrum of antibody immunity across several SARS-CoV-2 variants

Researchers evaluated antibody responses to the spike proteins of the SARS-CoV-2 Wuhan-Hu-1 strain and VOCs such as the Alpha, Beta, Gamma, Delta, and Omicron.

16 Jan 2023

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

Acceptance of COVID-19 vaccines increased overall by 5.2% in 2022 compared to 2021, according to a survey of 160,000 individuals in 23 countries, published in the journal Nature Medicine.

13 Jan 2023

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

In a recent review, the former director of the National Institute of Allergy and Infectious Diseases and former chief medical advisor to the president of the United States (U.S.), Dr. Fauci, and his team review the roadblocks to developing effective vaccines against viruses that infect the human respiratory mucosa and discuss strategies for next-generation vaccine development against mucosal respiratory viruses

13 Jan 2023

Strong bonds with close social circles and extended groups associated with better mental health, wellbeing

The time people spent with family over the festive period could have improved their health, according to new research which examined how social bonds with close social circles and extended groups relate to health and psychological wellbeing.

13 Jan 2023

Participants using Huma's clinical trial platform have high levels of engagement in COVID-19 study

Huma Therapeutics Limited ("Huma"), a leading global digital health company, today announced results of a new study in collaboration with the Medical Research Council Epidemiology Unit at the University of Cambridge showing that participants using Huma's clinical trial platform had high, sustained levels of engagement in an observational, fully remote COVID-19 study.

13 Jan 2023

The role of sleep behavior in developmental executive function outcomes in children during COVID-19 confinement

Researchers assessed the protective effect of sleep on children's executive skills during COVID-19 isolation.

13 Jan 2023

Pandemic News and Research

Further Reading

What does the future of clinical trials and evidence-based medicine look like?

COVID-19 is changing behaviors related to how people are exposed to household chemicals

Threshold control method could aid in future non-pharmaceutical intervention relaxation policy making

Exploring a novel amplicon-based mpox virus sequencing strategy

What older Americans need to know about taking Paxlovid

After a brief pandemic reprieve, rural workers return to life without paid leave

Cancer mortality in the U.S. has declined 33% since the 90s

Future COVID-19 control will require vaccines that induce better mucosal immunity

Modification to Hospital Elder Life Program expands delirium prevention

Rural seniors benefit from pandemic-driven remote fitness boom

New community diagnostic center set to benefit thousands of patients in Stockton-on-Tees

New type of CT scan lights up the obvious cause of hypertension

Intranasal mRNA-lipid nanoparticle vaccines elicit significant protection against SARS-CoV-2 in hamsters

What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?

Study investigates the spectrum of antibody immunity across several SARS-CoV-2 variants

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

Strong bonds with close social circles and extended groups associated with better mental health, wellbeing

Participants using Huma's clinical trial platform have high levels of engagement in COVID-19 study

The role of sleep behavior in developmental executive function outcomes in children during COVID-19 confinement

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News